Phathom Pharmaceuticals Inc (PHAT)
7.74
+0.41
(+5.59%)
USD |
NASDAQ |
Jan 03, 16:00
7.735
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Total Long Term Debt (Quarterly): 175.73M for Sept. 30, 2024
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Merck & Co Inc | 38.13B |
| Galectin Therapeutics Inc | -- |
| AbbVie Inc | 71.08B |
| Poseida Therapeutics Inc | 58.91M |
| Janux Therapeutics Inc | 0.00 |